poractant alfa pulmonary surfactant sold brand name curosurf chiesi farmaceutici poractant alfa extract natural porcine lung surfactant surfactants marked improvement oxygenation may occur within minutes administration poractant alfa new generic form surfactant varasurf sheep lung surfactant developed persisgen co commercialized arnagen pharmad fully comparable quality profile curosurf milliliter poractant alfa contains mg surfactant extract includes mg phospholipids mg protein mg surfactant protein b spb depending local country registration curosurf available ml vials ml vials andor twin packs containing two ml vialscitation needed amount phospholipids calculated content phosphorus contains mg phosphatidylcholine mg dipalmitoylphosphatidylcholine transient episodes bradycardia decreased oxygen saturation hypotension endotracheal tube blockage may occurcitation needed endogenous pulmonary surfactant reduces surface tension airliquid interface alveoli mechanical ventilation stabilizes alveoli collapse resting transpulmonary deficiency pulmonary surfactant preterm infants results respiratory distress syndrome poractant alfa compensates surfactant deficiency restores surface activity lung tissuecitation needed surfactant deficiency identified cause respiratory distress syndrome rds long ago trials surfactant replacement unsuccessful preparations used contained phospholipids administered inefficiently nebulization bengt robertson göran enhörning showed natural surfactant containing phospholipids proteins could ameliorate signs rds immature rabbits bengt robertson tore curstedt developed porcine surfactant curosurf named surnames effective immature animals used pilot clinical trial beginning subsequent randomized clinical trials planned year later bengt robertson tore curstedt henry halliday first trial begun showed curosurf reduced pulmonary air leaks neonatal mortality preterm infants severe rds second trial coordinated christian p speer demonstrated multiple doses curosurf effective single dose subsequent trials conducted collaborative european multicenter study group included among others guilio bevilacqua janna koppe ola saugstad nils svenningsen jeanpierre relier showed early treatment effective later administration infants treated birth similar neurodevelopmental status untreated controls corrected age years members collaborative european multicenter study group denmark sweden performed studies demonstrate benefits combination surfactant treatment early continuous positive airway surfactants marked improvements oxygenation may occur within minutes administration curosurf httpsenwikipediaorgwikiporactantalfa